Neurocrine Biosciences | Utile Per Azione


Fiscal Calendario Efettivo Consenso Precedente Data
FY2025Q4 Dec/2025 1.88 1.86 1.69 Feb/11 2026
FY2025Q3 Sep/2025 2.17 1.56 1.81 Oct/28 2025
FY2025Q2 Jun/2025 1.65 0.98 1.63 Jul/30 2025
FY2025Q1 Mar/2025 0.70 0.86 1.20 May/05 2025
FY2024Q4 Dec/2024 1.69 1.57 1.54 Feb/06 2025




Eps Cambiamento Data
AbbVie USD 2.71 0.85 2025-12
Acadia Pharmaceuticals USD 0.42 0.26 2025-09
Agios Pharmaceuticals USD -1.86 0.08 2025-12
ALKERMES USD 0.29 0.2 2025-12
Alnylam Pharmaceuticals USD 1.25 1.65 2025-12
Amgen USD 5.29 0.35 2025-12
Biogen USD 1.99 2.82 2025-12
BioMarin Pharmaceutical USD 0.46 0.34 2025-12
Cytokinetics USD -1.5 1.05 2025-12
Enanta Pharmaceuticals USD -1.05 0.31 2024-12
Exelixis USD 0.97 0.19 2025-12
Gilead Sciences USD 1.86 0.61 2025-12
Halozyme Therapeutics USD -0.24 1.96 2025-12
Incyte USD 1.8 0.46 2025-12
Ionis Pharmaceuticals USD -1.41 0.61 2025-12
Nektar Therapeutics USD -0.18 0.07 2024-09
Neurocrine Biosciences USD 1.88 0.29 2025-12
Pfizer USD 0.66 0.21 2025-12
Prothena USD -0.68 1.66 2025-09
Regeneron Pharmaceuticals USD 11.44 0.39 2025-12
Repligen USD 0.49 0.03 2025-12
Rigel Pharmaceuticals USD 0.7 0.76 2024-09
Sarepta Therapeutics USD -0.13 2.15 2025-09
Teva Pharmaceutical Industries USD 2.98 0.43 2025-12
Ultragenyx Pharmaceutical USD -1.29 0.52 2025-12
Vertex Pharmaceuticals USD 5.03 0.23 2025-12
Xoma USD -1.59 2.43 2024-09


Neurocrine Biosciences Utile Per Azione - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.